T1	Condition 475 492	evaluable disease
T2	Condition-Name 475 492	evaluable disease
E1	Condition:T1 Name:T2
T3	Condition 523 540	evaluable disease
T4	Condition-Name 523 540	evaluable disease
E3	Condition:T3 Name:T4
T5	Condition 583 600	measurable lesion
T6	Condition-Name 583 600	measurable lesion
E5	Condition:T5 Name:T6
T7	Condition 604 607	per
T8	Condition-Name 604 607	per
E7	Condition:T7 Name:T8
T9	Procedure 1336 1363	bone marrow transplantation
T10	Procedure-Name 1336 1363	bone marrow transplantation
E9	Procedure:T9 Name:T10
T11	Condition 638 657	disease progression
T12	Condition-Name 638 657	disease progression
E11	Condition:T11 Name:T12
T13	Procedure 1253 1269	targeted therapy
T14	Procedure-Name 1253 1269	targeted therapy
E13	Procedure:T13 Name:T14
T15	Procedure 1042 1054	radiotherapy
T16	Procedure-Name 1042 1054	radiotherapy
E15	Procedure:T15 Name:T16
T17	Eq-Operator 1144 1153	less than
A1	Eq-Operator-Value T17 LT
T18	Eq-Operator 1167 1169	<=
A2	Eq-Operator-Value T18 LTEQ
T19	Eq-Operator 1508 1510	<=
A3	Eq-Operator-Value T19 LTEQ
T20	Eq-Temporal-Unit 990 995	weeks
A4	Eq-Temporal-Unit-Value T20 week
T21	Eq-Temporal-Unit 1513 1519	months
A5	Eq-Temporal-Unit-Value T21 month
T22	Eq-Value 41 42	1
T23	Eq-Value 292 293	2
T24	Eq-Value 435 439	2016
T25	Eq-Value 499 500	1
T26	Eq-Value 567 568	2
T27	Eq-Value 839 840	2
T28	Eq-Value 988 989	2
T29	Eq-Value 1171 1172	1
